Search results
Lovelace Respiratory Research Institute. Lovelace Biomedical Research Institute is a private contract research organization that is part of Touro University and New York Medical College (NYMC). It was founded after WWII in Albuquerque, New Mexico by two physicians, William Randolph Lovelace I and his nephew, surgeon William Randolph Lovelace II.
Lovelace Biomedical conducts basic and applied research in respiratory disease and neuroscience/mental health. It has expertise in lung cancer, COPD, aerosol science, infectious disease, and neuroimaging.
Lovelace Biomedical is a not-for-profit preclinical contract research organization that offers services in toxicology, drug development, and disease characterization. It is affiliated with a family of companies that provide nonclinical and clinical research, and has expertise in inhalation delivery of gene therapies and opioid overdose prevention.
People also ask
What does Lovelace Biomedical Research Institute do?
Who founded the Lovelace Respiratory Research Institute?
What is Lovelace scientific resources?
What is Lovelace's infectious disease program?
Lovelace Biomedical is a world leader in respiratory drug delivery, physiology, and toxicology for nearly 60 years. It offers preclinical and clinical services for respiratory pharmacology, inhalation exposure, and complex respiratory testing.
LRRI is a national and international leader in respiratory research, offering aerosol science, inhalation therapy, asthma, COPD, infectious disease, and other programs. LRRI collaborates with academic institutions, government agencies, and private entities to conduct research and development projects using specialized facilities and equipment.
Browse the publications of LRRI, a non-profit research organization dedicated to improving human health and well-being. Find articles on asthma, cancer, COPD, drug development, environmental toxicology, and more.
Read the latest issue of Breathe, a magazine featuring the research and innovation of LRRI scientists. Learn how LRRI bridges the gap between national defense and public health, and how it commercializes products to improve respiratory health.
